# To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension

> **NCT07051811** · NA · RECRUITING · sponsor: **Lepu Medical Technology (Beijing) Co., Ltd.** · enrollment: 213 (estimated)

## Conditions studied

- Essential Hypertension

## Interventions

- **PROCEDURE:** Intravascular Ultrasound Ablation Therapy
- **PROCEDURE:** Renal Artery Angiography

## Key facts

- **NCT ID:** NCT07051811
- **Lead sponsor:** Lepu Medical Technology (Beijing) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-25
- **Primary completion:** 2027-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 213 (ESTIMATED)
- **Last updated:** 2025-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07051811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07051811, "To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07051811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*